Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Impact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight Heparins (LMWHs) on Survival in Patients with Locally Advanced or Metastatic Lung Cancer (LC) Receiving Chemotherapy

Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD, Thein H. Oo, MD

Blood (2019) 134 (Supplement_1): 3466.

https://doi.org/10.1182/blood-2019-128561

Published: 2019

Journal Articles

Combination of DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Neil L Berinstein, MD, Isabelle Bence-Bruckler, MD, Pierre Laneuville, MD FRCPC, Douglas A. Stewart, MD, Nicholas Allen Forward, MDMSc,FRCPC, Liam Smyth, MDFRCPath, Gail Klein, MSc, Nancy Pennell, BSc, Kim Roos, BA, BSc

Blood (2019) 134 (Supplement_1): 3236.

https://doi.org/10.1182/blood-2019-125963

Published: 2019

Journal Articles

DT2216, a Synthetic Proteolytic Selectively Targeting Bcl-X L for Ubiquitination and Degradation in Tumor Cells but Not in Platelets, Is a Safer and More Potent Antitumor Agent Than Navitoclax

Sajid Khan, PhD, Xuan Zhang, BMBS, Dongwen Lv, PhD, Yonghan He, MD, Peiyi Zhang, MS, Xingui Liu, PhD, Dinesh Thummuri, PhD, Qi Zhang, PhD, Marina Y. Konopleva, MD PhD, Robert A. Hromas, MD, Guangrong Zheng, Daohong Zhou, MD

Blood (2018) 132 (Supplement 1): 2698.

https://doi.org/10.1182/blood-2018-99-114762

Published: 2018

Journal Articles

Acalabrutinib in Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): Updated Results from the Phase 1/2 ACE-CL-001 Study

John C. Byrd, MD, Jennifer A. Woyach, MD, Richard R. Furman, MD, Peter Martin, FRCPC, MD MS, Susan M. O'Brien, MD, Jennifer R. Brown, MD PhD, Deborah M. Stephens, Jacqueline C. Barrientos, MD, Stephen Devereux, PhD, Peter Hillmen, MB ChB, PhD FRCP, FRCPath, John M. Pagel, MD PhD, Dih-Yih Chen, MD, Ahmed Hamdy, MD, Raquel Izumi, PhD, Priti Patel, MD, Min Hui Wang, PhD, Nitin Jain, MD, William G. Wierda, MD PhD

Blood (2018) 132 (Supplement 1): 692.

https://doi.org/10.1182/blood-2018-99-110451

Published: 2018

Journal Articles

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Jo-Anne Vergilio, MD, Laurie M Gay, PhD, Lei Zhong, PhD, Mark Rosenzweig, PhD, Yakov Chudnovsky, PhD, Jie He, PhD, Michelle Nahas, PhD, Siraj M Ali, MD PhD, Sugganth Daniel, MD, Shakti Ramkissoon, MD PhD, James Suh, MD, Julia A Elvin, MD PhD, Tariq I Mughal, MD FRCP, Philip J Stephens, PhD, Vincent A Miller, MD, Rachel Erlich, PhD, Jeffrey S Ross, MD, Eric A Severson, MD PhD MMSc, Samantha Morley, PhD

Blood (2017) 130 (Supplement 1): 417.

https://doi.org/10.1182/blood.V130.Suppl_1.417.417

Published: 2017

Journal Articles

hLL2-Cys-PBD, a New Site-Specifically Conjugated, Pyrrolobenzodiazepine (PBD) Dimer-Based Antibody Drug Conjugate (ADC) Targeting CD22-Expressing B-Cell Malignancies.

Francesca Zammarchi, PhD, Simon Corbett, Lauren Adams, Maria Mellinas-Gomez, PhD, Peter Tyrer, PhD, Sandamali Dissanayake, Simone Sims, Karin Havenith, PhD, Simon Chivers, PhD, David G Willimas, PhD, Philip W Howard, PhD, John A. Hartley, PhD, Patrick van Berkel, PhD

Blood (2016) 128 (22): 4176.

https://doi.org/10.1182/blood.V128.22.4176.4176

Published: 2016

Journal Articles

Sonic Estimation of Elasticity Via Resonance Sonorheometry to Predict Thrombotic Risk in Patients with Cancer

Erin McLoughlin, MD, Elisa Ferrante, Francesco Viola, Hillary S. Maitland, MD MS

Blood (2016) 128 (22): 4996.

https://doi.org/10.1182/blood.V128.22.4996.4996

Published: 2016

Journal Articles

Ibrutinib in Early Stage CLL: Preliminary Safety Results of a Placebo-Controlled Phase III Study

Petra Langerbeins, MD, Jasmin Bahlo, Christina Rhein, Paula Cramer, MD, Anna-Maria Fink, MD, Natali Pflug, MD, Julia von Tresckow, MD, Stephan Stilgenbauer, MD, Karl-Anton Kreuzer, Michael J. Eckart, MD, Ursula Vehling-Kaiser, MD, Rudolf Schlag, MD, Christina Balser, MD, Lothar Müller, MD, Clemens-Martin Wendtner, MD, Kirsten Fischer, MD, Barbara Eichhorst, MD, Michael Hallek, MD

Blood (2015) 126 (23): 2934.

https://doi.org/10.1182/blood.V126.23.2934.2934

Published: 2015

Journal Articles

Engineering the Cancer Genome

Tyler Jacks, PhD

Blood (2015) 126 (23): SCI-19.

https://doi.org/10.1182/blood.V126.23.SCI-19.SCI-19

Published: 2015

Journal Articles

Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial

Davide Gianfreda, Maria Nicastro, Maricla Galetti, Federico Alberici, Domenico Corradi, Gabriella Becchi, Giorgio Baldari, Massimo De Filippo, Stefania Ferretti, Gabriella Moroni, Rosario Foti, Marcella Di Gangi, Guido Jeannin, Raphael Saffroy, Jean-François Emile, Carlo Buzio, Augusto Vaglio

Blood (2015) 126 (10): 1163–1171.

https://doi.org/10.1182/blood-2015-01-620377

Published: 2015

Includes: Supplemental data

Journal Articles

Small cell lung cancer mimicking high-grade lymphoma in a patient with concurrent B-cell lymphoproliferative disorder

Ioannis Politikos, Yuri Sheikine

Blood (2015) 126 (8): 1041.

https://doi.org/10.1182/blood-2015-05-647644

Published: 2015

Journal Articles

Pegylated Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory and/or Elder Acute Myeloid Leukemia: The Preliminary Result of Phase II Trial

Hui-Jen Tsai, MD PhD, Ming-Chung Wang, MD, Sheng-Fung Lin, MD, Ya-Ping Chen, MD PhD, Hui-Hwa Hsiao, MD PhD, Ching-Yuan Kuo, MD, Li-Tzong Chen, MD PhD, Tsai-Yun Chen, MD

Blood (2014) 124 (21): 984.

https://doi.org/10.1182/blood.V124.21.984.984

Published: 2014

Journal Articles

Targeting the CXCR4 Pathway: Safety, Tolerability and Clinical Activity of Ulocuplumab (BMS-936564), an Anti-CXCR4 Antibody, in Relapsed/Refractory Acute Myeloid Leukemia

Pamela S. Becker, MD PhD, James M. Foran, MD, Jessica K. Altman, MD, Abdulraheem Yacoub, MD MB, Januario E. Castro, MD, Peter Sabbatini, PhD, Clifford Dilea, Mark Wade, Guan Xing, PhD, Andres Gutierrez, MD PhD, Lewis Cohen, MD MS, B. Douglas Smith, MD

Blood (2014) 124 (21): 386.

https://doi.org/10.1182/blood.V124.21.386.386

Published: 2014

Journal Articles

Relationship Between Severity and Duration of Chemotherapy Induced Neutropenia and Risk of Infection Among Patients with Non-Myeloid Malignancies

Yanli Li, MDPhD, Xiaolong Shih, PhD, Zandra K. Klippel, MD, Maureen Reiner, M.S., John H Page, MD ScD

Blood (2014) 124 (21): 4960.

https://doi.org/10.1182/blood.V124.21.4960.4960

Published: 2014

Journal Articles

miRNA Expression Profiling in Mesenchymal Stromal/Stem Cells Derived from G-CSF Primed Bone Marrows

Aysen Gunel-Ozcan, MDPhD, Ilgin Cagnan, MSc, Emin Kansu, MD, Duygu Uckan, MD

Blood (2014) 124 (21): 5140.

https://doi.org/10.1182/blood.V124.21.5140.5140

Published: 2014

Journal Articles

Risk of Intracranial Hemorrhage Associated with Enoxaparin Administration in Patients with Brain Metastasis

Jessica Donato, MD, Federico Campigotto, MS, Erika Coletti, BSN, Donna Neuberg, ScD, Griffin Weber, MD PhD, Jeffrey I. Zwicker, MD

Blood (2014) 124 (21): 348.

https://doi.org/10.1182/blood.V124.21.348.348

Published: 2014

Journal Articles

Blocking Protein Secretion and Degradation Is a Novel Treatment Strategy For Malignant Cells With High Protein Load

Eric Lowe, Rebecca Maglathlin, Alana Lerner, Ph.D, Jack Taunton, PhD, Christopher J. Kirk, Ph.D, Shirin Arastu-Kapur, Ph.D

Blood (2013) 122 (21): 4439.

https://doi.org/10.1182/blood.V122.21.4439.4439

Published: 2013

Journal Articles

Surface Expressions of Platelet Glycoprotein Ibα, GpIIb/IIIa, and P-Selectin Are Elevated in Lung Cancer Patients

Jiansheng Zhang, Lili Zhao, Jianan Huang, Pingping Zhang, Kesheng Dai

Blood (2012) 120 (21): 4655.

https://doi.org/10.1182/blood.V120.21.4655.4655

Published: 2012

Journal Articles

Incidence and Outcomes of a Rare Translocation t(3,5) in Patients (pts) with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Mona Lisa Alattar, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Tapan M. Kadia, M.D., Gautam Borthakur, M.D., Maro Ohanian, DO, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Alfonso Quintas-Cardamas, MD, Elias Jabbour, Naval Daver, MD, Sherry A. Pierce, RN, BS, Mark Brandt, BS, Stefan Faderl, MD, Naveen Pemmaraju, M.D.

Blood (2012) 120 (21): 1456.

https://doi.org/10.1182/blood.V120.21.1456.1456

Published: 2012

Journal Articles

Inflammatory and Thrombotic Mediators in Small Cell Lung Carcinoma: Potential Role in Thromboembolic Complications

Debra Hoppensteadt, Ph.D., Hussein Khan, Indermohan Thethi, MD, Muzaffer Demir, MD, Cafer Adiguzel, MD, Saud Rahman, Jawed Fareed, PhD

Blood (2011) 118 (21): 2294.

https://doi.org/10.1182/blood.V118.21.2294.2294

Published: 2011

NARROW

Impact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight Heparins (LMWHs) on Survival in Patients with Locally Advanced or Metastatic Lung Cancer (LC) Receiving Chemotherapy

Combination of DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

DT2216, a Synthetic Proteolytic Selectively Targeting Bcl-X L for Ubiquitination and Degradation in Tumor Cells but Not in Platelets, Is a Safer and More Potent Antitumor Agent Than Navitoclax

Acalabrutinib in Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): Updated Results from the Phase 1/2 ACE-CL-001 Study

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

hLL2-Cys-PBD, a New Site-Specifically Conjugated, Pyrrolobenzodiazepine (PBD) Dimer-Based Antibody Drug Conjugate (ADC) Targeting CD22-Expressing B-Cell Malignancies.

Sonic Estimation of Elasticity Via Resonance Sonorheometry to Predict Thrombotic Risk in Patients with Cancer

Ibrutinib in Early Stage CLL: Preliminary Safety Results of a Placebo-Controlled Phase III Study

Engineering the Cancer Genome

Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial

Small cell lung cancer mimicking high-grade lymphoma in a patient with concurrent B-cell lymphoproliferative disorder

Pegylated Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory and/or Elder Acute Myeloid Leukemia: The Preliminary Result of Phase II Trial

Targeting the CXCR4 Pathway: Safety, Tolerability and Clinical Activity of Ulocuplumab (BMS-936564), an Anti-CXCR4 Antibody, in Relapsed/Refractory Acute Myeloid Leukemia

Relationship Between Severity and Duration of Chemotherapy Induced Neutropenia and Risk of Infection Among Patients with Non-Myeloid Malignancies

miRNA Expression Profiling in Mesenchymal Stromal/Stem Cells Derived from G-CSF Primed Bone Marrows

Risk of Intracranial Hemorrhage Associated with Enoxaparin Administration in Patients with Brain Metastasis

Blocking Protein Secretion and Degradation Is a Novel Treatment Strategy For Malignant Cells With High Protein Load

Surface Expressions of Platelet Glycoprotein Ibα, GpIIb/IIIa, and P-Selectin Are Elevated in Lung Cancer Patients

Incidence and Outcomes of a Rare Translocation t(3,5) in Patients (pts) with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Inflammatory and Thrombotic Mediators in Small Cell Lung Carcinoma: Potential Role in Thromboembolic Complications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only